IL33 and neoplasm: STC1 may influence CD4+ T cells to secrete cytokines, including IL-17, IL-31, and IL-33, which modulate immune responses via autocrine or paracrine mechanisms, thereby either amplifying or suppressing immune activity within the tumor microenvironment [30].